Subscribe

Get latest conversations to your inbox

If you're enjoying this conversation, please subscribe to stay tuned for upcoming conversations.

Chris Koddermann (ITPRI) : Rescheduling Psilocybin Globally

March 3, 2022

Chris Koddermann of the International Therapeutic Psilocybin Initiative is pushing for the ​​UN to reschedule psilocybin.

Psilocybin is quickly becoming recognized as an effective modality for treating depression, anxiety, and other mental health challenges. Yet, the road to decriminalization and legalization of the medicine in the US and on a global scale is still slow going. Join us today with Chris Koddermann of the International Therapeutic Psilocybin Initiative, or ITPRI, to discuss his push for theUN to reclassifies psilocybin as a less dangerous drug.

We begin with Chris’s introduction to psychedelics. He shares his motivation to work pro bono to get psilocybin rescheduling passed. We discuss the Convention of Psychotropic Substances of 1971 and what decriminalization actually means. We close with a deep dive on this  current psilocybin initiative, what it means to regulate psilocybin, psilocybin availability, and how you can get involved in moving change forward.

Chris Koddermann is the co-founder and chair of the Board of Directors for the International Therapeutic Psilocybin Initiative (ITPRI). ITPRI brings together an international coalition of leading psychedelic therapy advocacy and research organizations to promote and secure a rescheduling of psilocybin under the 1971 UN Convention on Psychotropic Substances.

Links

Contact

  • info@reschedulepsilocybin.org

Timestamps

  • :05 - Being ‘out’ in the psychedelic space while working in legislation
  • :09 - Why do unpaid work  to get psilocybin legislation passed?
  • :13 - The Single Convention on Narcotic Drugs (1961) & The Convention of Psychotropic Substances (1971)
  • :17 - Current restrictions on psilocybin research
  • :19 - Decriminalization explained
  • :22 - Rescheduling psychedelics
  • :31 – Psilocybin Coalition and ITPRI
  • :34 - Lessons learned from the rescheduling of cannabis and next steps in psilocybin legalization
  • :38 - How to regulate the productions of psilocybin

Show notes

Links

Contact

  • info@reschedulepsilocybin.org

Timestamps

  • :05 - Being ‘out’ in the psychedelic space while working in legislation
  • :09 - Why do unpaid work  to get psilocybin legislation passed?
  • :13 - The Single Convention on Narcotic Drugs (1961) & The Convention of Psychotropic Substances (1971)
  • :17 - Current restrictions on psilocybin research
  • :19 - Decriminalization explained
  • :22 - Rescheduling psychedelics
  • :31 – Psilocybin Coalition and ITPRI
  • :34 - Lessons learned from the rescheduling of cannabis and next steps in psilocybin legalization
  • :38 - How to regulate the productions of psilocybin
LinkedIn pink iconInstagram pink iconFacebook pink iconTwiter pink iconYoutube pink icon

About Maya’s Podcast

A conversation series with leaders in the psychedelic community. Designed in service of therapists, healers, retreat leaders, and passionate enthusiasts

View all episodes

Other podcasts you may also like

August 18, 2022

Alexandre Tannous: Psychedelics & Sound Meditation

Can sound help us disconnect from unhealthy habitual patterns? Today’s guest Alexandre Tannous, creator of the Sound Meditation protocol, shows how we can use harmonic frequencies to release trauma, enhance self-awareness and live happier lives.

Listen to Podcast
June 10, 2022

Talia Eisenberg (Beond): How Ibogaine Gets to the Root of Trauma

The West African psychedelic iboga (and its extraction ibogaine) continues to show an impressive ability to heal addiction and trauma.

Listen to Podcast
May 5, 2022

Adele Lafrance: Healing Eating Disorders with Psychedelics

The promising impact that ayahuasca, MDMA, ketamine, and psilocybin can have on a person who is struggling to heal from disordered eating.

Listen to Podcast